Praxsyn Corporation
PXYN · OTC
9/30/2019 | 6/30/2019 | 3/31/2019 | 9/30/2015 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $20 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $3 |
| Gross Profit | $0 | $0 | $0 | $18 |
| % Margin | 58.3% | – | – | 85.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $0 | $0 | $0 | $12 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $10 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $12 |
| Operating Income | -$0 | -$0 | -$0 | $5 |
| % Margin | -279.1% | – | – | 26.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | $6 |
| Tax Expense | $0 | $0 | $0 | $3 |
| Net Income | -$0 | -$0 | -$0 | $3 |
| % Margin | -338.7% | – | – | 14.5% |
| EPS | -0 | -0 | -0 | 0.005 |
| % Growth | -100% | -107.8% | -101% | – |
| EPS Diluted | -0 | -0 | -0 | 0.002 |
| Weighted Avg Shares Out | 789 | 764 | 742 | 628 |
| Weighted Avg Shares Out Dil | 789 | 764 | 742 | 1,400 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | $5 |
| % Margin | -279.1% | – | – | 26.6% |